Angiotensin II stimulation of DPP4 activity regulates megalin in the proximal tubules

International Journal of Molecular Sciences

Volumn 17, Issue 5, 2016, Pages

  Aroor, Annayya ^a,b   Zuberek, Marcin ^a   Duta, Cornel ^a   Meuth, Alex ^a,b   Sowers, James R ^a,b   Whaley Connell, Adam ^a,b   Nistala, Ravi ^a,b  

^a University of Missouri   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

AT1R; DPP4; EGFR; ERK; Megalin; Obesity related kidney disease; Proteinuria

Indexed keywords

ANGIOTENSIN II; ANGIOTENSINOGEN; DIPEPTIDYL PEPTIDASE IV; EPIDERMAL GROWTH FACTOR RECEPTOR; MEGALIN; MITOGEN ACTIVATED PROTEIN KINASE; DPP4 PROTEIN, MOUSE; ENZYME INHIBITOR; LRP2 PROTEIN, MOUSE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; KIDNEY PROXIMAL TUBULE; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; COMPLICATION; GENE EXPRESSION REGULATION; METABOLISM; MOUSE MUTANT; OBESITY; RENAL INSUFFICIENCY;

ANGIOTENSIN II; ANIMALS; CELL LINE; DIPEPTIDYL PEPTIDASE 4; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; KIDNEY TUBULES, PROXIMAL; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-2; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, OBESE; OBESITY; RENAL INSUFFICIENCY;

EID: 84982130996     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17050780     Document Type: Article

References (46)

1. Flegal, K.M.; Carroll, M.D.; Ogden, C.L.; Curtin, L.R. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010, 303, 235-241. [CrossRef] [PubMed]
2. Ogden, C.L.; Carroll, M.D.; Kit, B.K.; Flegal, K.M. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014, 311, 806-814. [CrossRef] [PubMed]
3. Johnson, R.J.; Segal, M.S.; Sautin, Y.; Nakagawa, T.; Feig, D.I.; Kang, D.H.; Gersch, M.S.; Benner, S.; Sánchez-Lozada, L.G. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am. J. Clin. Nutr. 2007, 86, 899-906. [PubMed]
4. Nistala, R.; Whaley-Connell, A. Resistance to insulin and kidney disease in the cardiorenal metabolic syndrome; role for angiotensin II. Mol. Cell. Endocrinol. 2013. [CrossRef] [PubMed]
5. Hall, J.E. The kidney, hypertension, and obesity. Hypertension 2003, 41, 625-633. [CrossRef] [PubMed]
6. Littlejohn, N.K.; Grobe, J.L. Opposing tissue-specific roles of angiotensin in the pathogenesis of obesity, and implications for obesity-related hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2015, 309, R1463-R1473. [CrossRef] [PubMed]
7. Yvan-Charvet, L.; Quignard-Boulange, A. Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity. Kidney Int. 2011, 79, 162-168. [CrossRef] [PubMed]
8. Grassi, G.; Seravalle, G.; Dell’Oro, R.; Trevano, F.Q.; Bombelli, M.; Scopelliti, F.; Facchini, A.; Mancia, G.; Study, C. Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: Results of the CROSS study. J. Hypertens. 2003, 21, 1761-1769. [CrossRef] [PubMed]
9. Massiera, F.; Bloch-Faure, M.; Ceiler, D.; Murakami, K.; Fukamizu, A.; Gasc, J.M.; Quignard-Boulange, A.; Negrel, R.; Ailhaud, G.; Seydoux, J.; et al. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J. 2001, 15, 2727-2729. [CrossRef] [PubMed]
10. Yiannikouris, F.; Gupte, M.; Putnam, K.; Thatcher, S.; Charnigo, R.; Rateri, D.L.; Daugherty, A.; Cassis, L.A. Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice. Hypertension 2012, 60, 1524-1530. [CrossRef] [PubMed]
11. Gekle, M. Renal tubule albumin transport. Annu. Rev. Physiol. 2005, 67, 573-594. [CrossRef] [PubMed]
12. Guzik, T.J.; Hoch, N.E.; Brown, K.A.; McCann, L.A.; Rahman, A.; Dikalov, S.; Goronzy, J.; Weyand, C.; Harrison, D.G. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J. Exp. Med. 2007, 204, 2449-2460. [CrossRef] [PubMed]
13. Cheng, H.F.; Becker, B.N.; Burns, K.D.; Harris, R.C. Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule. J. Clin. Investig. 1995, 95, 2012-2019. [CrossRef] [PubMed]
14. Ren, Z.; Liang, W.; Chen, C.; Yang, H.; Singhal, P.C.; Ding, G. Angiotensin II induces nephrin dephosphorylation and podocyte injury: Role of caveolin-1. Cell Signal. 2012, 24, 443-450. [CrossRef] [PubMed]
15. Tojo, A.; Onozato, M.L.; Kurihara, H.; Sakai, T.; Goto, A.; Fujita, T. Angiotensin II blockade restores albumin reabsorption in the proximal tubules of diabetic rats. Hypertens. Res. 2003, 26, 413-419. [CrossRef] [PubMed]
16. Kawarazaki, W.; Nagase, M.; Yoshida, S.; Takeuchi, M.; Ishizawa, K.; Ayuzawa, N.; Ueda, K.; Fujita, T. Angiotensin II- and salt-induced kidney injury through Rac1-mediated mineralocorticoid receptor activation. J. Am. Soc. Nephrol. 2012, 23, 997-1007. [PubMed]
17. Hosojima, M.; Sato, H.; Yamamoto, K.; Kaseda, R.; Soma, T.; Kobayashi, A.; Suzuki, A.; Kabasawa, H.; Takeyama, A.; Ikuyama, K.; et al. Regulation of megalin expression in cultured proximal tubule cells by angiotensin II type 1A receptor- and insulin-mediated signaling cross talk. Endocrinology 2009, 150, 871-878. [CrossRef] [PubMed]
18. Gonzalez-Villalobos, R.; Klassen, R.B.; Allen, P.L.; Johanson, K.; Baker, C.B.; Kobori, H.; Navar, L.G.; Hammond, T.G. Megalin binds and internalizes angiotensin-(1-7). Am. J. Physiol. Ren. Physiol. 2006, 290, F1270-F1275. [CrossRef] [PubMed]
19. Riquier-Brison, A.D.; Leong, P.K.; Pihakaski-Maunsbach, K.; McDonough, A.A. Angiotensin II stimulates trafficking of NHE3, NaPi2, and associated proteins into the proximal tubule microvilli. Am. J. Physiol. Ren. Physiol. 2010, 298, F177-F186. [CrossRef] [PubMed]
20. Tiruppathi, C.; Miyamoto, Y.; Ganapathy, V.; Roesel, R.A.; Whitford, G.M.; Leibach, F.H. Hydrolysis and transport of proline-containing peptides in renal brush-border membrane vesicles from dipeptidyl peptidase IV-positive and dipeptidyl peptidase IV-negative rat strains. J. Biol. Chem. 1990, 265, 1476-1483. [PubMed]
21. Lee, J.W.; Chou, C.L.; Knepper, M.A. Deep sequencing in microdissected renal tubules identifies nephron segment-specific transcriptomes. J. Am. Soc. Nephrol. 2015, 26, 2669-2677. [CrossRef] [PubMed]
22. Girardi, A.C.; Fukuda, L.E.; Rossoni, L.V.; Malnic, G.; Reboucas, N.A. Dipeptidyl peptidase IV inhibition downregulates Na+-H+ exchanger NHE3 in rat renal proximal tubule. Am. J. Physiol. Ren. Physiol. 2008, 294, F414-F422. [CrossRef] [PubMed]
23. Nistala, R.; Habibi, J.; Lastra, G.; Manrique, C.; Aroor, A.R.; Hayden, M.R.; Garro, M.; Meuth, A.; Johnson, M.; Whaley-Connell, A.; et al. Prevention of obesity-induced renal injury in male mice by DPP4 inhibition. Endocrinology 2014, 155, 2266-2276. [CrossRef] [PubMed]
24. Nistala, R.; Habibi, J.; Aroor, A.; Sowers, J.R.; Hayden, M.R.; Meuth, A.; Knight, W.; Hancock, T.; Klein, T.; DeMarco, V.G.; et al. DPP4 Inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese rat. Obesity 2014. [CrossRef]
25. Yang, J.; Campitelli, J.; Hu, G.; Lin, Y.; Luo, J.; Xue, C. Increase in DPP-IV in the intestine, liver and kidney of the rat treated with high fat diet and streptozotocin. Life Sci. 2007, 81, 272-279. [CrossRef] [PubMed]
26. Liu, W.J.; Xie, S.H.; Liu, Y.N.; Kim, W.; Jin, H.Y.; Park, S.K.; Shao, Y.M.; Park, T.S. Dipeptidyl peptidase IV inhibitor attenuates kidney injury in streptozotocin-induced diabetic rats. J. Pharmacol. Exp. Ther. 2012, 340, 248-255. [CrossRef] [PubMed]
27. Mega, C.; de Lemos, E.T.; Vala, H.; Fernandes, R.; Oliveira, J.; Mascarenhas-Melo, F.; Teixeira, F.; Reis, F. Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker diabetic fatty rat). Exp. Diabetes Res. 2011, 2011, 162092. [CrossRef] [PubMed]
28. Lee, S.A.; Kim, Y.R.; Yang, E.J.; Kwon, E.J.; Kim, S.H.; Kang, S.H.; Park, D.B.; Oh, B.C.; Kim, J.; Heo, S.T.; et al. CD26/DPP4 levels in peripheral blood and T cells in patients with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 2013, 98, 2553-2561. [CrossRef] [PubMed]
29. Sun, A.L.; Deng, J.T.; Guan, G.J.; Chen, S.H.; Liu, Y.T.; Cheng, J.; Li, Z.W.; Zhuang, X.H.; Sun, F.D.; Deng, H.P.; et al. Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease. Diabetes Vasc. Dis. Res. 2012, 9, 301-308. [CrossRef] [PubMed]
30. Whaley-Connell, A.; Habibi, J.; Panfili, Z.; Hayden, M.R.; Bagree, S.; Nistala, R.; Hyder, S.; Krueger, B.; Demarco, V.; Pulakat, L.; et al. Angiotensin II activation of mTOR results in tubulointerstitial fibrosis through loss of N-cadherin. Am. J. Nephrol. 2011, 34, 115-125. [PubMed]
31. Ma, L.J.; Corsa, B.A.; Zhou, J.; Yang, H.; Li, H.; Tang, Y.W.; Babaev, V.R.; Major, A.S.; Linton, M.F.; Fazio, S.; et al. Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity. Am. J. Physiol. Ren. Physiol. 2011, 300, F1203-F1213.
32. Arruda-Junior, D.F.; Virgulino, S.G.; Girardi, A.C. Reduced tubular proteinuria in hypertensive rats treated with losartan is associated with higher renal cortical megalin expression. Horm. Mol. Biol. Clin. Investig. 2014, 18, 105-112. [PubMed]
33. Lamers, D.; Famulla, S.; Wronkowitz, N.; Hartwig, S.; Lehr, S.; Ouwens, D.M.; Eckardt, K.; Kaufman, J.M.; Ryden, M.; Müller, S.; et al. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 2011, 60, 1917-1925. [PubMed]
34. Bilodeau, N.; Fiset, A.; Poirier, G.G.; Fortier, S.; Gingras, M.C.; Lavoie, J.N.; Faure, R.L. Insulin-dependent phosphorylation of DPP-IV in liver. Evidence for a role of compartmentalized c-Src. FEBS J. 2006, 273, 992-1003. [PubMed]
35. Bauvois, B.; Djavaheri-Mergny, M.; Rouillard, D.; Dumont, J.; Wietzerbin, J. Regulation of CD26/DPP-IV gene expression by interferons and retinoic acid in tumor B cells. Oncogene 2000, 19, 265-272. [PubMed]
36. Rohrborn, D.; Wronkowitz, N.; Eckel, J. DPP4 in Diabetes. Front. Immunol. 2015, 6, 386. [CrossRef] [PubMed]
37. Chien, C.H.; Tsai, C.H.; Lin, C.H.; Chou, C.Y.; Chen, X. Identification of hydrophobic residues critical for DPP-IV dimerization. Biochemistry 2006, 45, 7006-7012. [CrossRef] [PubMed]
38. Chung, K.M.; Cheng, J.H.; Suen, C.S.; Huang, C.H.; Tsai, C.H.; Huang, L.H.; Chen, Y.R.; Wang, A.H.; Jiaang, W.T.; Hwang, M.J.; et al. The dimeric transmembrane domain of prolyl dipeptidase DPP-IV contributes to its quaternary structure and enzymatic activities. Protein Sci. 2010, 19, 1627-1638. [CrossRef] [PubMed]
39. Ravida, A.; Musante, L.; Kreivi, M.; Miinalainen, I.; Byrne, B.; Saraswat, M.; Henry, M.; Meleady, P.; Clynes, M.; Holthofer, H. Glycosylation patterns of kidney proteins differ in rat diabetic nephropathy. Kidney Int. 2015. [CrossRef] [PubMed]
40. Coppo, M.; Boddi, M.; Bandinelli, M.; Degl’innocenti, D.; Ramazzotti, M.; Marra, F.; Galastri, S.; Abbate, R.; Gensini, G.F.; Poggesi, L.; et al. Angiotensin II upregulates renin-angiotensin system in human isolated T lymphocytes. Regul. Pept. 2008, 151, 1-6. [CrossRef] [PubMed]
41. Sadjadi, J.; Kramer, G.L.; Yu, C.H.; Welborn, M.B., 3rd; Modrall, J.G. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism. J. Surg. Res. 2005, 129, 272-277. [CrossRef] [PubMed]
42. Razga, Z.; Nyengaard, J.R. Up- and down-regulation of angiotensin II AT1-A and AT1-B receptors in afferent and efferent rat kidney arterioles. J. Renin Angiotensin Aldosterone Syst. 2008, 9, 196-201. [CrossRef] [PubMed]
43. Seta, K.; Sadoshima, J. Phosphorylation of tyrosine 319 of the angiotensin II type 1 receptor mediates angiotensin II-induced trans-activation of the epidermal growth factor receptor. J. Biol. Chem. 2003, 278, 9019-9026. [CrossRef] [PubMed]
44. Lautrette, A.; Li, S.; Alili, R.; Sunnarborg, S.W.; Burtin, M.; Lee, D.C.; Friedlander, G.; Terzi, F. Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: A new therapeutic approach. Nat. Med. 2005, 11, 867-874. [CrossRef] [PubMed]
45. Zou, Z.; Chung, B.; Nguyen, T.; Mentone, S.; Thomson, B.; Biemesderfer, D. Linking receptor-mediated endocytosis and cell signaling: Evidence for regulated intramembrane proteolysis of megalin in proximal tubule. J. Biol. Chem. 2004, 279, 34302-34310. [CrossRef] [PubMed]
46. Lu, H.; Boustany-Kari, C.M.; Daugherty, A.; Cassis, L.A. Angiotensin II increases adipose angiotensinogen expression. Am. J. Physiol. Endocrinol. Metab. 2007, 292, E1280-E1287. [CrossRef] [PubMed]